Elekta and Philips deepen strategic partnership in precise and individualized oncology care
Healthcare leaders partner to streamline the path from cancer diagnosis to survivorship for better outcomesSTOCKHOLM and AMSTERDAM, June 7, 2021 – Elekta (EKTA-B.ST) and Royal Philips (NYSE: PHG, AEX: PHIA) today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions. The extended collaboration builds on the two companies’ successful cooperation in the fast-emerging field of magnetic resonance (MR)-guided adaptive radiation therapy. Through deeper cross-portfolio collaboration, Elekta and